Log in
Enquire now
‌

US Patent 8722715 Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions

Patent 8722715 was granted and assigned to NovaBay Pharmaceuticals on May, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8722715
Date of Patent
May 13, 2014
Patent Application Number
12612572
Date Filed
November 4, 2009
Patent Primary Examiner
‌
Michael Barker
Patent abstract

The present application relates to N-chlorinated oxazolidinone, hydantoin and imidazolidinone compounds of Formula I

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8722715 Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.